Generic medicine
Empagliflozin + Metformin
Empagliflozin + Metformin · Endocrine & metabolic · Antidiabetic medicines
Data statusRegistration & price fields require source verification.
130brands/products
12companies
130with current prices
Available dosage forms
Tap a form to filter the brand listChoose a form
Pakistan brand index
Available brands
| Brand | Manufacturer | Strength | Form | Pack | Reg. no. | Official price | Unit price |
|---|---|---|---|---|---|---|---|
| Adrance-M | Atco Laboratories Limited | 12.5 mg + 1000 mg | Tablet | 28’s | 095150 | PKR 1,659.572024-07-01 | PKR 59.27/ tablet |
| Adrance-M | Atco Laboratories Limited | 5 mg + 500 mg | Tablet | 28's | 105253 | PKR 1,333.222024-07-01 | PKR 47.62/ tablet |
| Adrance-M | Atco Laboratories Limited | 5 mg + 850 mg | Tablet | 7’s | 095148 | PKR 356.002024-07-01 | PKR 50.86/ tablet |
| Adrance-M | Atco Laboratories Limited | 5 mg + 1000 mg | Tablet | 28s | 095151 | PKR 1,402.442024-07-01 | PKR 50.09/ tablet |
| Adrance-M | Atco Laboratories Limited | 5 mg + 850 mg | Tablet | 28’s | 095148 | PKR 1,398.842024-07-01 | PKR 49.96/ tablet |
| Adrance-M | Atco Laboratories Limited | 12.5 mg + 850 mg | Tablet | 28s | 095147 | PKR 1,655.962024-07-01 | PKR 59.14/ tablet |
| Adrance-M | Atco Laboratories Limited | 12.5 mg + 850 mg | Tablet | 30s | 095147 | PKR 1,772.832024-07-01 | PKR 59.09/ tablet |
| Adrance-M | Atco Laboratories Limited | 12.5 mg + 500 mg | Tablet | 14's | 098695 | PKR 832.482024-07-01 | PKR 59.46/ tablet |
| Adrance-M | Atco Laboratories Limited | 5 mg + 500 mg | Tablet | 10's | 105253 | PKR 486.102024-07-01 | PKR 48.61/ tablet |
| Adrance-M | Atco Laboratories Limited | 5 mg + 500 mg | Tablet | 14's | 105253 | PKR 680.832024-07-01 | PKR 48.63/ tablet |
| Adrance-M | Atco Laboratories Limited | 5 mg + 500 mg | Tablet | 7's | 105253 | PKR 341.132024-07-01 | PKR 48.73/ tablet |
| Adrance-M | Atco Laboratories Limited | 12.5 mg + 500 mg | Tablet | 28's | 098695 | PKR 1,630.802024-07-01 | PKR 58.24/ tablet |
| Adrance-M | Atco Laboratories Limited | 12.5 mg + 850 mg | Tablet | 7s | 095147 | PKR 422.542024-07-01 | PKR 60.36/ tablet |
| Adrance-M | Atco Laboratories Limited | 5 mg + 500 mg | Tablet | 30's | 105253 | PKR 1,429.872024-07-01 | PKR 47.66/ tablet |
| Adrance-M | Atco Laboratories Limited | 5 mg + 1000 mg | Tablet | 14’s | 095151 | PKR 715.612024-07-01 | PKR 51.12/ tablet |
| Adrance-M | Atco Laboratories Limited | 12.5 mg + 1000 mg | Tablet | 14’s | 095150 | PKR 846.862024-07-01 | PKR 60.49/ tablet |
| Adrance-M | Atco Laboratories Limited | 5 mg + 850 mg | Tablet | 14’s | 095148 | PKR 713.822024-07-01 | PKR 50.99/ tablet |
| Adrance-M | Atco Laboratories Limited | 12.5 mg + 850 mg | Tablet | 14s | 095147 | PKR 845.062024-07-01 | PKR 60.36/ tablet |
| Adrance-M | Atco Laboratories Limited | 12.5 mg + 850 mg | Tablet | 10s | 095147 | PKR 602.342024-07-01 | PKR 60.23/ tablet |
| Diampa-M | Getz Pharma (Pvt) Limited | 5 mg + 850 mg | Tablet | 28's | 103093 | PKR 1,501.522024-07-01 | PKR 53.63/ tablet |
Independent editorial layer
Medicine information
Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.